Novo Nordisk's Wegovy shows heart benefits beyond weight loss, new data suggests

, November 17, 2023
Pharma

The effectiveness of Novo Nordisk's blockbuster obesity treatment Wegovy in reducing heart attacks and strokes could be due to more than weight loss alone, according to new clinical trial data.

Obesity drugs put these stocks on a crash diet—now they're rebounding

, November 17, 2023
Pharma

Medical-device investors bet new obesity drugs won't cause as much pain as previously thought.

Bernie pushes NIH to rein in drug prices

, November 17, 2023
Pharma

Can the NIH bring down drug prices? It doesn't approve new medicines or pay for them, but its role in drug research gives it surprising leverage.

Drugmaker Mallinckrodt emerges from bankruptcy

, November 15, 2023
Pharma

Drugmaker Mallinckrodt says it has emerged from bankruptcy and reduced its total funded debt by about $1.9 billion.

Wegovy is shown to reduce risk of heart attacks and strokes in some patients

, November 13, 2023
Pharma

The results of a large clinical trial suggest the obesity medication could also change the landscape of cardiovascular care.

For the first time, gene-editing provides hints for lowering cholesterol

, November 13, 2023
Pharma

Researchers have produced evidence that gene-editing can cut high cholesterol, a major risk factor for the nation's leading killer.

Pages